Shimadzu : NOTICE OF RESOLUTIONS AT THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

Note: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. The Company assumes no responsibility for this translation or for direct, indirect or any other forms of damages arising from the translation.

June 28, 2022

To Our Shareholders

Yasunori Yamamoto

Representative Director, President & CEO

SHIMADZU CORPORATION

1, Nishinokyo Kuwabara-cho,

Nakagyo-ku, Kyoto, Japan

NOTICE OF RESOLUTIONS AT

THE 159TH ANNUAL GENERAL MEETING OF SHAREHOLDERS

Dear Shareholders:

The following matters were reported and resolved at the 159th Annual General Meeting of Shareholders of SHIMADZU CORPORATION (the Company), held today.

Matters Reported : 1. The Business Report, Consolidated Financial Statements for the 159th Fiscal Year (April 1, 2021 - March 31, 2022) and results of audits of the Consolidated Financial Statements by the Accounting Auditor and the Audit & Supervisory Board

2. Non-consolidatedFinancial Statements for the 159th Fiscal Year (April 1, 2021 -

March 31, 2022)

The contents of the above documents were reported.

Matters Resolved :

Proposal 1: Appropriation of Surplus

Resolved as originally proposed by the Company, with the payment of year-end dividend of 28yen per share.

Proposal 2: Partial Amendments to the Articles of Incorporation

Resolved as originally proposed by the Company. The summaries of the amendments are as follows:

Since the system for providing informational materials for the general meeting of shareholders in electronic format has been established as providing for in the Act Partially Amending the Companies Act (Act No.70 of 2019), and the provisions of the amended Companies Act stipulates the system are to be enforced on September 1, 2022, necessary changes have been made in preparation for the introduction of the system.

Proposal 3: Election of Eight (8) Directors, Members of the Board

Mr. Teruhisa Ueda, Mr. Yasunori Yamamoto, Mr. Yasuo Miura, Ms. Hiroko Wada, Mr. Nobuo Hanai and Mr. Yoshiyuki Nakanishi were re-appointed, and Mr. Akira Watanabe and Ms. Nami Hamada were newly appointed, and all assumed their offices, as originally proposed by the Company.

Note: Ms. Hiroko Wada, Mr. Nobuo Hanai, Mr. Yoshiyuki Nakanishi and Ms. Nami Hamada are Outside Directors.

Proposal 4: Election of One (1) Substitute Audit & Supervisory Board Member

Mr. Fumio Iwamoto was appointed as a Substitute Audit & Supervisory Board

Member, as originally proposed by the Company.

Payment of Year-End Dividends

Please obtain your year-end dividend for the 159th Fiscal Year from any nearby office of Japan Post Bank Co., Ltd., or post office within the payment period (from Wednesday, June 29, 2022 to Friday, July 29, 2022) by presenting "Dividend Receipt."

For shareholders who have already designated a bank account or any other account to which dividends are to be remitted, please refer to "Dividend Statement" and "Reference to the Transfer Destination."

- 1 -

Executive Members

As a result of the resolutions passed at the meeting of the Board of Directors which was held after the conclusion of the Annual General Meeting of Shareholders, the Representative Directors have been appointed, and they have assumed their respective offices.

Therefore, the following is a list of the Company's Executive members as of June 28, 2022 (See, (1) below). The list of the Executive Officers and Corporate Officers as of April 1, 2022 is as follows (See, (2) and

(3) below).

We would like to express our appreciation for your continued support.

(1) Directors, Members of the Board and Audit & Supervisory Board Members

Representative	Director	Teruhisa Ueda
Representative	Director	Yasunori Yamamoto
Director, Member of the Board	Yasuo Miura
Director, Member of the Board	Akira Watanabe	(newly appointed)
Outside Director	Hiroko Wada
Outside Director	Nobuo Hanai
Outside Director	Yoshiyuki Nakanishi
Outside Director	Nami Hamada	(newly appointed)

Senior Audit & Supervisory	Hiroyuki Fujii
Board Member
Audit & Supervisory Board	Makoto Koyazaki
Member
Outside Audit & Supervisory	Masahiro Nishio
Board Member
Outside Audit & Supervisory	Tsuyoshi Nishimoto
Board Member

- 2 -

(2) Executive Officers

Name	Current Position	Responsibility at the Company
	Chairman of the Board
	[Reasons for appointment]
	As Chairman of the Board, he is running the Board appropriately and is
Teruhisa Ueda *	committed to enhancing corporate value by strengthening corporate
governance. Based on his abundant experience and a distinguished track
(promoted)	record in a business in addition to having served as CEO with the strong
	leadership, the Company expects his role in strengthening the Board's
	functions for decision-making on important matters and for monitoring
	and oversight of business execution, and has newly appointed him as a
	Chairman of the Board.
	President & CEO
	[Reasons for appointment]
	Responsible for management of the Group as the CEO, he is committed
	to enhancing corporate value and promoting the medium-term
Yasunori Yamamoto *	management plan. He has abundant knowledge and track record in the
(promoted)	field of engineering and manufacturing, and management of an overseas
	subsidiary in addition to having served as CFO responsible for Corporate
	Strategy Planning and Corporate Communication. Therefore, the
	Company expects his role in promoting the medium-term management
	plan and enhancing corporate value, and has newly appointed him as a
	President & CEO.
	Senior Corporate	In charge of Risk Management and
	Corporate Marketing
	Executive Officer
	General Manager, Tokyo Office
	[Reasons for appointment]
	Responsible for Risk Management and Corporate Marketing, he is
Yasuo Miura *	committed to improving the risk management system and strengthening
	the corporate marketing organization. Based on his abundant knowledge
	and track record in finance and accounting, sales operations and
	management of an overseas subsidiary, the Company expects his role in
	leading the improvement of the risk management system and sales
	capabilities, and continues to appoint him as a Senior Corporate
	Executive Officer.
	Senior Managing	General Manager,
	Analytical & Measuring Instruments
	Executive Officer
	Division
	[Reasons for appointment]
	As General Manager of Analytical & Measuring Instruments Division, he
Yoshiaki Mase	is committed to expanding the business and enhancing the functions of
	the organization. Based on his abundant knowledge and track record in
	the international business including in China and offering operational
	efficiency through the information technology, the Company expects his
	role in contributing to the growth and improving the profitability of the
	Analytical & Measuring Instruments business, and continues to appoint
	him as a Senior Managing Executive Officer.

- 3 -

Name	Current Position	Responsibility at the Company
	Senior Managing	In charge of DX･IT Strategy
	Executive Officer	Jointly in charge of Technology Research
	[Reasons for appointment]
	Responsible for DX･IT Strategy, he is committed to the business model
Kunimasa Ito	change, organizational and corporate cultural reforms by utilizing digital
	technology. Based on his abundant knowledge and track record in medical
	business, which is increasingly getting digitized, the Company expects
	his role in accelerating DX promotion leading to the creation of customer
	value, and continues to appoint him as a Senior Managing Executive
	Officer.
	Senior Managing	Managing Director,
	Shimadzu (Hong Kong) Ltd.
	Executive Officer
	(Currently posted to China)
	[Reasons for appointment]
Shuzo Maruyama	As Managing Director of the Company's business in China, he is
committed to expanding the business performance with strong leadership.
	Based on his abundant knowledge and track record in Analytical &
	Measuring Instruments business and the business in the U.S.A., the
	Company expects his role in taking advantage of new business
	opportunities and appropriately managing the risks, and continues to
	appoint him as a Senior Managing Executive Officer.
	Senior Managing	CFO
	In charge of Corporate Strategy Planning
	Executive Officer
	and Corporate Communication
	[Reasons for appointment]
	As the CFO, responsible for Corporate Strategy Planning and Corporate
Akira Watanabe *	Communication, he is committed to enhancing corporate value and
(promoted)	promoting the medium-term management plan. Based on his abundant
	knowledge and track record in sales operations, marketing, and
	management of an overseas subsidiary in addition to having served as
	General Manager of the Industrial Machinery business and Fluidics
	Systems business, the Company expects his role in contributing to the
	Group's sustainable growth and enhancing corporate value, and has
	newly appointed him as a Senior Managing Executive Officer.

- 4 -

Name	Current Position	Responsibility at the Company
		CSO (Chief of Standardization
		Officer)
	Managing Executive Officer	In charge of Global Environmental
	Management and Medical Regulations
		Jointly in charge of Corporate Strategy
		Planning
Fuminori Inagaki	[Reasons for appointment]
As CSO (Chief of Standardization Officer), responsible for Global
	Environmental Management and Medical Regulation, he is committed to
	developing new markets and enhancing social values of the Group. Based
	on his abundant knowledge and track record in understanding economic
	policies and the latest market trends, the Company expects his role in
	enhancing corporate value and solving challenges in society through
	collaboration with external firm, and has appointed him as a Managing
	Executive Officer.
		In charge of Manufacturing and
	Managing Executive Officer	CS Management
		Jointly in charge of DX･IT Strategy
	[Reasons for appointment]
Katsuaki Kaito	Responsible for Manufacturing and CS Management, he is committed to
the quality improvement, cost reduction and shortening of the lead time
	for delivery. Based on his abundant knowledge and track record in
	technology & manufacturing fields and management of an overseas
	subsidiary, the Company expects his role in optimizing the manufacturing
	functions to improve the quality and reduce costs, and continues to
	appoint him again as a Managing Executive Officer.
	Managing Executive Officer	General Manager,
		Medical Systems Division
	[Reasons for appointment]
	As General Manager of Medical Systems Division, he is committed to
Koki Aoyama	expanding the business and increasing the profitability. Based on his
	abundant knowledge and track record in marketing and service fields in
	addition to the management of an overseas subsidiary, the Company
	expects his role in further improving the profitability and expand the
	overseas business, and has appointed him as a Managing Executive
	Officer.

- 5 -